Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupradiotherapyThoracic TumorsDiseaseLung Carcinoma, Small CellSubgroupICD10C34.-MeSHSmall Cell Lung CarcinomaSequenceCISP80/ETOP100/Radiation, SCLC, A (PID266) -|- IRIN60/CISP60, B (PID267)ChemotherapyChemo-substanceCarboplatinCisplatinEtoposideChemo-substanceCarboplatinCisplatinEtoposideChemo-substanceCarboplatinCisplatinEtoposideChemo-substanceCarboplatinCisplatinEtoposideNo. Substances2 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideNo. Substances578Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseInductionTherapy intentioncurativepalliativeRisksAlopeciaAnemia Hb below 8g/dlElectrolyte DisturbanceEmetogenicity (MASCC/ESMO)EsophagitisFebrile NeutropeniaLeukopeniaNeutropeniaThrombocytopenia below 50 000/µl only studiesPublicationAuthorFaivre-Finn CSaito HSkarlos DVTakada MTurrisi ATDiseasekleinzelliges Lungenkarzinom, limited disease, ECOG 0-2SCLC, limited diseaseSCLC, limited disease, ECOG 0-2SCLC, limited disease, ECOG: 0-2, CONVERT TrialSCLC, limited disease exclusive Stadium IOriginAthens Medical Center, GreeceDivision of Molecular and Clinical Cancer Sciences, University of Manchester, UKDivision of Molecular and Clinical Cancer Sciences, University of Manchester, UK, CONVERT studyJapan Clinical Oncology Group, Studie 9104Medical University of South Carolina, Charleston, USAWest Japan Thoracic Oncology Group 9902Protocols in Revision 6 protocols foundProtocols under revision.Carboplatin 6 / Etoposide 100 / Radiation, Small Cell Lung Cancer (PID2267 V1.0)Cisplatin 25 / Etoposide 100 / Radiation, Small Cell Lung Carcinoma, Small Cell (PID1256 V1.1)Cisplatin 60 / Etoposide 120 / Radiation, Small Cell Lung Carcinoma, Small Cell (PID264 V1.2)Cisplatin 75 / Etoposide 100 / Radiation, Small Cell Lung Carcinoma, Small Cell (PID1254 V1.1)Cisplatin 80 / Etoposide 100 / Radiation, Small Cell Lung Carcinoma, Small Cell (PID265 V1.2)Cisplatin 80 / Etoposide 100 / Radiation, Small Cell Lung Cancer, Part A (PID266 V1.2)
